Prothena Plc Stock Buy Hold or Sell Recommendation
| PRTA Stock | USD 14.15 0.40 2.75% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Prothena plc is 'Strong Sell'. Macroaxis provides Prothena Plc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRTA positions.
Check out Prothena Plc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide. In addition, we conduct extensive research on individual companies such as Prothena and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Prothena |
Execute Prothena Plc Buy or Sell Advice
The Prothena recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Prothena plc. Macroaxis does not own or have any residual interests in Prothena plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Prothena Plc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Prothena Plc Trading Alerts and Improvement Suggestions
| Prothena plc generated a negative expected return over the last 90 days | |
| Prothena plc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 91.37 M. Net Loss for the year was (147.03 M) with loss before overhead, payroll, taxes, and interest of (81.66 M). | |
| Prothena plc currently holds about 508.8 M in cash with (133.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.84. | |
| Prothena plc has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Prothena Co. plc Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat |
Prothena Plc Returns Distribution Density
The distribution of Prothena Plc's historical returns is an attempt to chart the uncertainty of Prothena Plc's future price movements. The chart of the probability distribution of Prothena Plc daily returns describes the distribution of returns around its average expected value. We use Prothena plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Prothena Plc returns is essential to provide solid investment advice for Prothena Plc.
| Mean Return | -0.41 | Value At Risk | -7.46 | Potential Upside | 5.44 | Standard Deviation | 4.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Prothena Plc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Prothena Stock Institutional Investors
| Shares | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 719.3 K | Boxer Capital Llc | 2024-09-30 | 690 K | Rock Springs Capital Management Lp | 2024-09-30 | 625 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 526.7 K | Prosight Management, Lp | 2024-09-30 | 483.5 K | Finepoint Capital Lp | 2024-09-30 | 433.5 K | Goldman Sachs Group Inc | 2024-09-30 | 415.3 K | Federated Hermes Inc | 2024-09-30 | 404.9 K | Northern Trust Corp | 2024-09-30 | 372.7 K | Ecor1 Capital, Llc | 2024-09-30 | 11.6 M | Fmr Inc | 2024-09-30 | 8.1 M |
Prothena Plc Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Free Cash Flow | (53.5M) | (80.6M) | 92.0M | (109.3M) | (136.7M) | (129.9M) | |
| Depreciation | 6.8M | 7.0M | 6.8M | 744K | 928K | 881.6K | |
| Capital Expenditures | 555K | 196K | 575K | 464K | 2.8M | 1.9M | |
| Net Income | (77.7M) | (111.1M) | 67.0M | (116.9M) | (147.0M) | (139.7M) | |
| Change To Inventory | (396.2M) | 9.6M | (10.3M) | (8.9M) | (10.2M) | (10.7M) | |
| Change In Cash | (53.3M) | (80.3M) | 282.4M | 132.2M | (91.6M) | (87.0M) | |
| End Period Cash Flow | 378.4M | 298.1M | 580.4M | 712.6M | 621.0M | 440.1M | |
| Change Receivables | (62K) | 238K | 53K | 15K | 17.3K | 16.4K | |
| Other Non Cash Items | 37.3M | 28.2M | 38.7M | 6.0M | 7.5M | 12.0M | |
| Change To Netincome | (1.2M) | (1.7M) | 4.6M | 20.2M | 23.2M | 24.4M | |
| Investments | (547K) | (196K) | (575K) | (464K) | (1.4M) | (1.5M) |
Prothena Plc Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Prothena Plc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Prothena Plc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Prothena stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.77 | |
β | Beta against Dow Jones | 3.03 | |
σ | Overall volatility | 4.57 | |
Ir | Information ratio | -0.12 |
Prothena Plc Volatility Alert
Prothena plc exhibits very low volatility with skewness of -0.48 and kurtosis of 4.0. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Prothena Plc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Prothena Plc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Prothena Plc Fundamentals Vs Peers
Comparing Prothena Plc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Prothena Plc's direct or indirect competition across all of the common fundamentals between Prothena Plc and the related equities. This way, we can detect undervalued stocks with similar characteristics as Prothena Plc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Prothena Plc's fundamental indicators could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Prothena Plc to competition |
| Fundamentals | Prothena Plc | Peer Average |
| Return On Equity | -0.23 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Profit Margin | (0.99) % | (1.27) % |
| Operating Margin | (68.57) % | (5.51) % |
| Current Valuation | 265.46 M | 16.62 B |
| Shares Outstanding | 53.81 M | 571.82 M |
| Shares Owned By Insiders | 13.45 % | 10.09 % |
| Shares Owned By Institutions | 97.00 % | 39.21 % |
| Number Of Shares Shorted | 7.88 M | 4.71 M |
| Price To Earning | 37.12 X | 28.72 X |
| Price To Book | 1.45 X | 9.51 X |
| Price To Sales | 5.87 X | 11.42 X |
| Revenue | 91.37 M | 9.43 B |
| Gross Profit | (81.66 M) | 27.38 B |
| EBITDA | (190.11 M) | 3.9 B |
| Net Income | (147.03 M) | 570.98 M |
| Cash And Equivalents | 508.8 M | 2.7 B |
| Cash Per Share | 10.84 X | 5.01 X |
| Total Debt | 11.84 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 13.00 X | 2.16 X |
| Book Value Per Share | 9.93 X | 1.93 K |
| Cash Flow From Operations | (133.91 M) | 971.22 M |
| Short Ratio | 17.11 X | 4.00 X |
| Earnings Per Share | (2.46) X | 3.12 X |
| Price To Earnings To Growth | 0.80 X | 4.89 X |
| Target Price | 59.0 | |
| Number Of Employees | 173 | 18.84 K |
| Beta | 0.16 | -0.15 |
| Market Capitalization | 782.92 M | 19.03 B |
| Total Asset | 696.38 M | 29.47 B |
| Retained Earnings | (980.03 M) | 9.33 B |
| Working Capital | 582.39 M | 1.48 B |
Note: Disposition of 66 shares by Walker Karin L of Prothena Plc at 68.9572 subject to Rule 16b-3 [view details]
Prothena Plc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Prothena . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 18059.82 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.37 | |||
| Day Typical Price | 14.29 | |||
| Price Action Indicator | (0.41) | |||
| Period Momentum Indicator | (0.40) | |||
| Relative Strength Index | 45.08 |
About Prothena Plc Buy or Sell Advice
When is the right time to buy or sell Prothena plc? Buying financial instruments such as Prothena Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Prothena Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Transportation Thematic Idea Now
Transportation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Transportation theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Transportation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Prothena Plc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 2.482 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.23) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.